Processing 00000000.tx.1: Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme1 Frederick G. 

Phrase: "Regulation of Multicatalytic Enzyme Activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   891   C1327623:regulation of enzyme activity [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the Insulin-Degrading Enzyme1 Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Hamel, Robert G. 

Phrase: "Hamel,"

Phrase: "Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Bennett and William C. 

Phrase: "Bennett"

Phrase: "and"

Phrase: "William C."
Processing 00000000.tx.4: Duckworth Veterans Affairs Medical Center, the Departments of Medicine and Pharmacology (F.G.H.) and Biochemistry and Molecular Biology (R.G.B., W.C.D.), University of Nebraska Medical Center, Omaha, Nebraska 68198-3020 Address all correspondence and requests for reprints to: William C. 

Phrase: "Duckworth Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "the Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "(F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H.)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(R.G.B.,"

Phrase: "W.C.D."

Phrase: ")"

Phrase: ","

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68198-3020"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027523:Nebraska [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "William C."
Processing 00000000.tx.5: Duckworth, M.D., University of Nebraska Medical Center, 600 South 42nd Street, Omaha, Nebraska 68198-3020.  

Phrase: "Duckworth,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "600 South 42nd Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442658:Street [Manufactured Object]
   812   C1301826:Street [Finding]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68198-3020."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027523:Nebraska [Geographic Area]
Processing 00000000.tx.6: Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The insulin-degrading enzyme (IDE) plays an important role in the cellular metabolism of insulin. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the cellular metabolism of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.7: Recent studies have also suggested a regulatory role for this protein in controlling the activity of cytoplasmic protein complexes, including the proteasome [multicatalytic proteinase (MCP)] and the glucocorticoid and androgen receptors. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a regulatory role for this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the activity of cytoplasmic protein complexes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1537044:protein activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "[multicatalytic proteinase (MCP)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "]"

Phrase: "and"

Phrase: "the glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "and"

Phrase: "androgen receptors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0034786:Receptors, Androgen [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]
Processing 00000000.tx.8: Binding of IDE to these complexes increases their activity, whereas the addition of substrates for IDE inhibits activity. 

Phrase: "Binding of IDE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1149286:enzyme binding [Molecular Function]
   797   C1623517:insulin binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to these complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "the addition of substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "for IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.9: This provides a potential mechanism of action for internalized insulin and other IDE substrates in the control of protein turnover. 

Phrase: "This"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a potential mechanism of action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0031327:mechanism of action [Physiologic Function]
   862   C1524059:mechanism of action [Functional Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "for internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "other IDE substrates in the control of protein turnover."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0178623:enzyme substrate [Chemical Viewed Functionally]
   704   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.10: To examine further the interactions, partially purified IDE-MCP complex was treated with EDTA or EGTA, and activity was measured in the absence and presence of various divalent cations (Ca2+, Mn2+, Co2+, and Zn2+) and insulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "partially purified IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   850   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   836   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2258865:multicatalytic proteinase [Molecular Function]
   793   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0439855:Complex [Qualitative Concept]
   793   C1622131:proteinase [Molecular Function]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1947941:Proteinase [Enzyme]

Phrase: "was"

Phrase: "treated with EDTA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured in the absence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "presence of various divalent cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "Co2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.11: EDTA treatment reduced MCP activity and eliminated the effect of insulin on the complex. 

Phrase: "EDTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "MCP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.12: Divalent cations partially or completely restored MCP activity, but did not restore the effect of insulin. 

Phrase: "Divalent cations partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   827   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "restored"

Phrase: "MCP activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restore"

Phrase: "the effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.13: EGTA treatment had a lesser effect on MCP activity, but abolished insulin inhibition of activity. 

Phrase: "EGTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "a lesser effect on MCP activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "abolished insulin inhibition of activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.14: Divalent cations restored the insulin effect. 

Phrase: "Divalent cations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "restored"

Phrase: "the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.15: Inhibitors of IDE also blocked the insulin effect on MCP activity, as did treatment with SDS. 

Phrase: "Inhibitors of IDE also"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   783   C0021643:inhibitors insulin [Pharmacologic Substance]
   783   C1152555:enzyme inhibitors [Molecular Function]
   783   C2756995:Enzyme Inhibitors [Molecular Function]
   767 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the insulin effect on MCP activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "did"

Phrase: "treatment with SDS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.16: These findings suggest that conformational changes in the complex may play a role in the insulin control of MCP activity.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that conformational changes in the complex"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0301641:Conformational change [Molecular Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the insulin control of MCP activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.17: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  INSULIN-DEGRADING enzyme (IDE; EC 3.4.24.56), is an intracellular protein with binding, regulatory, and degradative functions. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "INSULIN-DEGRADING enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "; EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "an intracellular protein with binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulatory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220905:regulatory [Regulation or Law]
  1000   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "degradative functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.18: In vitro, its most characteristic function is proteolytic activity, with a relatively high specificity for insulin, thus leading to its name (1). 

Phrase: "In vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "its most characteristic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "proteolytic activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "with a relatively high specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "for insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "thus"

Phrase: "leading to its name"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0027365:Name [Intellectual Product]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1547383:Name [Intellectual Product]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Although insulin is the substrate with the highest affinity, IDE also degrades a number of other peptides and hormones, including glucagon (2), insulin-like growth factor II (3), atrial natriuretic peptide (4), and transforming growth factor- (5). 

Phrase: "Although"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the substrate with the highest affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "IDE also"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrades"

Phrase: "a number of other peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "hormones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "insulin-like growth factor II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: It is not a general proteinase, because it does not degrade a wide variety of other similarly sized peptides, and no specific amino acid sequence is required for proteolysis (2). 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a general proteinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "because"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "degrade"

Phrase: "a wide variety of other similarly sized peptides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "no specific amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   923   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "required for proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0597304:Proteolysis [Molecular Function]
   790   C1514873:Required [Functional Concept]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: These findings have led to the conclusion that IDE recognizes a three-dimensional structure for binding and degradation (5, 6). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "led to the conclusion"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1707478:Conclusion [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "a three-dimensional structure for binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0450363:3-Dimensional [Spatial Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.22: The requirement for a specific ligand structure is reflected in the binding properties of IDE. 

Phrase: "The requirement for a specific ligand structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]

Phrase: "is"

Phrase: "reflected in the binding properties of IDE."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   762   C1149286:enzyme binding [Molecular Function]
   762   C1623517:insulin binding [Molecular Function]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0243122:binding [Functional Concept]
   742   C0558058:reflected [Mental Process]
   742   C0871161:properties [Qualitative Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1292721:properties [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]
Processing 00000000.tx.23: This protein binds proinsulin, insulin-like growth factor I, and epidermal growth factor with high affinities, but has little degrading activity toward them (7). 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "insulin-like growth factor I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "epidermal growth factor with high affinities,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1323367:epidermal growth factor [Molecular Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0014520:Epidermal [Tissue]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0221920:Epidermal [Spatial Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "has"

Phrase: "little degrading activity toward them"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.24: In fact, IDE was first identified in Drosophila by its binding properties and was considered a new intracellular growth factor receptor (8). 

Phrase: "In fact,"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified in Drosophila"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013138:Drosophila [Eukaryote]
   790   C0205396:Identified [Qualitative Concept]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "by its binding properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a new intracellular growth factor receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.25: The regulatory properties of IDE are a relatively new finding. 

Phrase: "The regulatory properties of IDE"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "are"

Phrase: "a relatively new finding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1268649:New finding [Finding]
   827   C0037088:Finding [Sign or Symptom]
   827   C0243095:Finding [Finding]
   827   C2825141:Finding [Finding]
Processing 00000000.tx.26: IDE associates with and activates the cytosolic glucocorticoid and androgen receptors (9, 10). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associates with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0750490:Associate [Idea or Concept]
   833   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the cytosolic glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "and"

Phrase: "androgen receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0034786:Receptors, Androgen [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.27: IDE also complexes with the proteasome and regulates its activity (11). 

Phrase: "IDE also complexes with the proteasome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "regulates"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.28: Substrates that bind to IDE, including insulin and the various growth factors, inhibit proteasome activity when IDE is complexed with multicatalytic proteinase (MCP), but not after separation of the two proteins (12, 13). 

Phrase: "Substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "that"

Phrase: "bind to IDE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the various growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "complexed with multicatalytic proteinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C2258865:multicatalytic proteinase [Molecular Function]
   770   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1622131:proteinase [Molecular Function]
   770   C1947941:Proteinase [Enzyme]
   737   C0439855:Complex [Qualitative Concept]
   737   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "after"

Phrase: "separation of the two proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.29: Furthermore, insulin inhibits proteasome activity toward an artificial substrate in intact cells (14). 

Phrase: "Furthermore,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteasome activity toward an artificial substrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.30: This has led to the hypothesis that intracellular actions of insulin and other growth factors on cellular protein turnover are due to interactions with IDE and inhibition of proteolysis by the proteasome. 

Phrase: "This"

Phrase: "has"

Phrase: "led to the hypothesis"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that intracellular actions of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "other growth factors on cellular protein turnover"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1868670:Other Growth [Finding]
   774   C0007595:Cellular Growth [Cell Function]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "are due to interactions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C1551058:Are [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737   C1704675:Interaction [Functional Concept]

Phrase: "with IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "inhibition of proteolysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2249698:inhibition of proteolysis [Organism Function]
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.31: IDE is a metalloenzyme containing Zn2+ and possibly Mn2+ (15), and its degradative activity requires one or more divalent cations (7). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a metalloenzyme containing Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "possibly Mn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its degradative activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "requires"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more divalent cations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   827   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.32: In addition to Zn2+ and Mn2+, Ca2+ has been shown to affect the degradative activity of IDE in vitro and in intact cells (16, 17). 

Phrase: "In addition to Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the degradative activity of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0243102:enzyme activity [Molecular Function]
   774   C1145751:insulin activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in intact cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.33: As Ca2+ and other divalent cations have been implicated in some of the activities of insulin (18), the present study is directed at examination of IDEs binding, regulatory, and degradative functions, with special emphasis on the effect of metals.  

Phrase: "As Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "other divalent cations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in some of the activities of insulin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   750   C1145751:insulin activity [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0441655:Activities [Activity]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "directed at examination of IDEs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0328104:Ide [Fish]
   760   C1415875:IDE [Gene or Genome]
   760   C2826366:IDE [Idea or Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: ","

Phrase: "regulatory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220905:regulatory [Regulation or Law]
  1000   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "degradative functions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "with special emphasis"

Phrase: "on the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of metals."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025552:Metals [Inorganic Chemical]
   916 E C2986473:Metallic [Qualitative Concept]
Processing 00000000.tx.34: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  [125I]Iodoinsulin specifically labeled on TyrA14 was provided by Dr. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "[125I"

Phrase: "]Iodoinsulin specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0063651:insulin, iodo- [Amino Acid, Peptide, or Protein]

Phrase: "labeled on TyrA14"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.35: Bruce Frank (Eli Lilly Research Laboratory, Indianapolis, IN) (19). 

Phrase: "Bruce Frank"

Phrase: "(Eli Lilly Research Laboratory,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0022886:research laboratory [Research Activity]
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN) (19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.36: Crystalline porcine insulin was provided by Dr. 

Phrase: "Crystalline porcine insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0039005:porcine [Mammal]
   827   C1135183:Porcine, NOS [Mammal]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.37: Ronald Chance (Eli Lilly Research Laboratory). 

Phrase: "Ronald Chance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0237506:Chance [Qualitative Concept]

Phrase: "(Eli Lilly Research Laboratory"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0022886:research laboratory [Research Activity]
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.38: Enzyme grade ammonium sulfate was purchased from ICN Biomedicals (Costa Mesa, CA). 

Phrase: "Enzyme grade ammonium sulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0002611:Ammonium [Inorganic Chemical]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "purchased from ICN Biomedicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Costa Mesa,"

Phrase: "CA)."
Processing 00000000.tx.39: Succinyl-Leu Leu-Val-Tyr-7-amino-4-methylcoumarin (LLVY), Boc-Leu-Ser-Thr-Arg-7-amino-4-methylcoumarin (LSTR), and CBZ-Leu-Leu-Glu -napthylamide (LLE) were purchased from Sigma (St. Louis, MO). 

Phrase: "Succinyl-Leu Leu-Val-Tyr-7-amino-4-methylcoumarin"

Phrase: "(LLVY"

Phrase: ")"

Phrase: ","

Phrase: "Boc-Leu-Ser-Thr-Arg-7-amino-4-methylcoumarin"

Phrase: "(LSTR"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CBZ-Leu-Leu-Glu -napthylamide"

Phrase: "(LLE)"

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.40: All chemicals were reagent grade or better. 

Phrase: "All chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "reagent grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441800:Grade [Classification]
   861   C0919553:Grade [Classification]
   861   C3244287:grade [Finding]

Phrase: "or"

Phrase: "better."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
Processing 00000000.tx.41: The enzyme preparation used was partially purified by ammonium sulfate fractionation (20). 

Phrase: "The enzyme preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0360722:Enzyme preparation [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "partially"

Phrase: "purified by ammonium sulfate fractionation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   760   C0002611:Ammonium [Inorganic Chemical]
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C1998793:Purified [Functional Concept]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   760   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.42: The enzyme was dialyzed overnight against at least 20 vol sodium acetate, pH 6.2, with no addition, 1 mM EDTA, or 1 mM EGTA, with three changes. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "dialyzed"

Phrase: "overnight against"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0439583:Overnight [Temporal Concept]

Phrase: "at least 20 vol sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 6.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with no addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "with three changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.43: EGTA is more specific for Ca2+ than EDTA, with EGTA binding Ca2+ about 2.5 times more tightly (21). 

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "more specific for Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "than EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "with EGTA binding Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "about 2.5 times more tightly"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   840   C0450346:2 5 [Quantitative Concept]
   804   C0040223:times [Temporal Concept]
   804   C0740116:+2 [Quantitative Concept]
   804   C1632851:Times [Quantitative Concept]
   804   C2827735:2+ [Quantitative Concept]
   804   C2981700:2+ [Classification]
   771 E C3541383:Time [Temporal Concept]
   733 E C0442043:Temporal [Spatial Concept]
   733 E C2362314:Temporal [Temporal Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.44: Conversely, EDTA binds most other divalent cations (including Zn2+, Mn2+, and Co2+) 1010,000 times more tightly than EGTA. 

Phrase: "Conversely,"

Phrase: "EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "most other divalent cations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Zn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "Co2+) 1010,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "000 times more tightly than EGTA."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.45: Acetate salts of the divalent cations were added at the concentrations indicated. 

Phrase: "Acetate salts of the divalent cations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0036140:Salts [Chemical Viewed Structurally]
   719 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   719 E C0206136:Salt [Food,Inorganic Chemical]

Phrase: "were"

Phrase: "added at the concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1524062:Added [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.46: Measurement of degradative activity Insulin degradation was measured by trichloroacetic acid precipitation (22) and expressed as the percent soluble per 15 min. 

Phrase: "Measurement of degradative activity Insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0202098:Insulin measurement [Laboratory Procedure]
   753   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "measured by trichloroacetic acid precipitation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "expressed as the percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "soluble per 15 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.47: Degradations of LLVY, LSTR, and LLE were measured by incubating the enzyme sample with 13 M fluorogenic peptide in 0.1 M Tris buffer, pH 7.5 (assay volume, 1 ml), for 60 min at 37 C on a metabolic shaker (12). 

Phrase: "Degradations of LLVY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0243125:degradation [Functional Concept]
   756   C0699900:Degradation [Organism Function]

Phrase: "LSTR,"

Phrase: "and"

Phrase: "LLE"

Phrase: "were"

Phrase: "measured by incubating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1439852:incubating [Laboratory Procedure]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the enzyme sample with 13 M fluorogenic peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "in 0.1 M Tris buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(assay volume,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "1 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C"

Phrase: "on a metabolic shaker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687735:Shaker [Population Group]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.48: Inhibitors or activators were included at the concentrations indicated. 

Phrase: "Inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "activators"

Phrase: "were"

Phrase: "included at the concentrations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0086045:Concentrations [Mental Process]
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.49: The reaction was stopped by the addition of 0.2 ml ethanol on ice. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 0.2 ml ethanol"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0001962:Ethanol [Organic Chemical]
   742   C0439526:/mL [Quantitative Concept]
   742   C1272691:stopped [Qualitative Concept]
   742   C1883712:Addition [Functional Concept]
   708 E C1947925:Stop [Activity]
   708 E C2746065:Stop [Temporal Concept]

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.50: The increase in fluorescence was measured on a fluorometer with excitation and emission wavelengths of 390 and 440 nm for LLVY and LSTR, and 335 and 410 nm for LLE. 

Phrase: "The increase in fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "measured on a fluorometer"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0180919:FLUOROMETER [Medical Device]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "with excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths of 390"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "440 nm for LLVY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "LSTR,"

Phrase: "and"

Phrase: "335"

Phrase: "and"

Phrase: "410 nm for LLE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]
Processing 00000000.tx.51: Data are expressed as the change in fluorescence units per 60 min and normalized with respect to the activity of untreated, uninhibited enzyme.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in fluorescence units"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2348686:Fluorescence Units [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "per 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "normalized with respect to the activity of untreated, uninhibited enzyme."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C0243102:enzyme activity [Molecular Function]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0205177:Activity [Functional Concept]
   739   C0332155:untreated [Finding]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0679133:respect [Social Behavior]
   739   C1561536:*Activity [Idea or Concept]
   739   C1882115:Normalized [Research Activity]
Processing 00000000.tx.52: Results Top Abstract Introduction Materials and Methods Results Discussion References  Insulin degradation by IDE is reduced by treatment with EDTA (Fig. 1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin degradation by IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3547574:insulin degradation [Molecular Function]
   783   C0678637:enzyme degradation [Laboratory Procedure]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "reduced by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0392756:Reduced [Qualitative Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with EDTA (Fig. 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.53: Ca2+ restores insulin degradative activity to EDTA-treated IDE at concentrations as low as 10-6 M. 

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "restores"

Phrase: "insulin degradative activity to EDTA-treated IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0243102:enzyme activity [Molecular Function]
   762   C1145751:insulin activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 10-6 M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0439187:/10^6 [Quantitative Concept]
   734   C1881839:10^6 [Quantitative Concept]
Processing 00000000.tx.54: At high Ca2+ concentrations (10-3 M), activity is increased above that of untreated enzyme (Fig. 1). 

Phrase: "At high Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(10-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883310:10^3 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "increased above that of untreated enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332155:untreated [Finding]
   753   C0442805:Increased [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.55: View larger version (14K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.56: Restoration by Ca2+ of EDTA inhibited insulin-degrading enzyme. 

Phrase: "Restoration by Ca2+ of EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449982:Restoration [Intellectual Product]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.57: EDTA treatment of IDE inhibits the enzyme by almost half, but readdition of Ca2+ restores the activity, and even increases it at 10-3 M. 

Phrase: "EDTA treatment of IDE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the enzyme by almost half,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "but"

Phrase: "readdition of Ca2+"

Phrase: "restores"

Phrase: "the activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "even"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "it at 10-3 M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1883310:10^3 [Quantitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.58: Values are the mean  SEM of IDE activity, expressed as a percentage of IDE without EDTA treatment.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the mean  SEM of IDE activity,"

Phrase: "expressed as a percentage of IDE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0439165:Percentage [Quantitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "without EDTA treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.59: The regulatory function of IDE is also affected by EDTA. 

Phrase: "The regulatory function of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "also"

Phrase: "affected by EDTA."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.60: Figure 2A shows that insulin inhibits LLVY degradation by the untreated IDE-MCP complex. 

Phrase: "Figure 2A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "LLVY degradation by the untreated IDE-MCP complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0678637:enzyme degradation [Laboratory Procedure]
   754   C3547574:insulin degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]
Processing 00000000.tx.61: The addition of Ca2+ slightly increases the activity of untreated complex, but does not alter the effect of insulin. 

Phrase: "The addition of Ca2+ slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the activity of untreated complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.62: EDTA treatment of the IDE-MCP complex decreases the chymotrypsin-like activity of MCP, as reflected by decreased degradation of LLVY (Fig. 2B). 

Phrase: "EDTA treatment of the IDE-MCP complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the chymotrypsin-like activity of MCP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C2258865:multicatalytic proteinase activity [Molecular Function]
   774   C1150095:proteinase activity [Molecular Function]
   774   C1150252:chymotrypsin activity [Molecular Function]
   774   C1622131:proteinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "reflected by decreased degradation of LLVY"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0205216:Decreased [Quantitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0558058:reflected [Mental Process]
   753   C0699900:Degradation [Organism Function]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.63: The addition of 10-510-3 M Ca2+ restores LLVY degradation, but not the insulin effect, although wide variability in the results can be seen. 

Phrase: "The addition of 10-510-3 M Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1883712:Addition [Functional Concept]

Phrase: "restores"

Phrase: "LLVY degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the insulin effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "although"

Phrase: "wide variability in the results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827666:Variability [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "seen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]
Processing 00000000.tx.64: View larger version (13K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.65: Effect of Ca2+ readdition on MCP, EDTA-treated MCP, and EGTA-treated MCP. 

Phrase: "Effect of Ca2+ readdition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on MCP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "EDTA-treated MCP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2258865:multicatalytic proteinase [Molecular Function]
   812   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1622131:proteinase [Molecular Function]
   812   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "EGTA-treated MCP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2258865:multicatalytic proteinase [Molecular Function]
   812   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1622131:proteinase [Molecular Function]
   812   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.66: A, Addition of Ca2+ has a slight stimulatory effect on LLVY degradation, with no effect on insulin inhibition. 

Phrase: "A,"

Phrase: "Addition of Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "has"

Phrase: "a slight stimulatory effect on LLVY degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "with no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.67: B, EDTA treatment reduces LLVY activity by 60% and eliminates the response to insulin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "EDTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "LLVY activity by 60%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "eliminates"

Phrase: "the response to insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
Processing 00000000.tx.68: Calcium addition reactivates the LLVY degradation, but does not restore insulin sensitivity. 

Phrase: "Calcium addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "reactivates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521123:reactivate [Functional Concept]

Phrase: "the LLVY degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restore"

Phrase: "insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.69: C, EGTA treatment reduces LLVY activity and essentially eliminates the response to insulin. 

Phrase: "C,"

Phrase: "EGTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "LLVY activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "essentially"

Phrase: "eliminates"

Phrase: "the response to insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
Processing 00000000.tx.70: Calcium addition restores both the degrading activity and the response to insulin. 

Phrase: "Calcium addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "restores"

Phrase: "both the degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the response to insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
Processing 00000000.tx.71: Values shown are the mean  SEM of LLVY activity, expressed as a percentage of that in the untreated enzyme.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of LLVY activity,"

Phrase: "expressed as a percentage of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in the untreated enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.72: There is evidence that IDE contains more than one divalent cation (15), a tightly bound Zn2+ and a more easily dissociable Mn2+, and that the different cations may have different effects on IDE activities. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "more than one divalent cation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007448:divalent cation [Chemical Viewed Structurally]
   760   C0007447:Cation [Chemical Viewed Structurally]
   760   C0205172:More [Functional Concept]
   760   C0205447:One [Quantitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "a tightly bound Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "a more easily dissociable Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "that"

Phrase: "the different cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "may"

Phrase: "have"

Phrase: "different effects on IDE activities."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.73: Thus, the effect of a different chelator, EGTA, was examined (Fig. 2C). 

Phrase: "Thus,"

Phrase: "the effect of a different chelator,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.74: Again, LLVY degradation was decreased, with only a slight further effect of insulin. 

Phrase: "Again,"

Phrase: "LLVY degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a slight further effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.75: Ca2+, however, restored both the LLVY degradative activity and the effect of insulin. 

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "however,"

Phrase: "restored"

Phrase: "both the LLVY degradative activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.76: Similar studies with EDTA- or EGTA-treated IDE-MCP complex were performed with the readdition of other cations (Zn2+, Mn2+, and Co2+) that alter IDE degradative activity (Figs. 3 and 4). 

Phrase: "Similar studies with EDTA-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "or"

Phrase: "EGTA-treated IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   850   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   836   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2258865:multicatalytic proteinase [Molecular Function]
   793   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0439855:Complex [Qualitative Concept]
   793   C1622131:proteinase [Molecular Function]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1947941:Proteinase [Enzyme]

Phrase: "were"

Phrase: "performed with the readdition of other cations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0007447:Cations [Chemical Viewed Structurally]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Zn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "Co2+)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "IDE degradative activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1145751:insulin activity [Molecular Function]
   853   C0243102:enzyme activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.77: The effects of Ca2+ are shown for comparison. 

Phrase: "The effects of Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "shown for comparison."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Comparison [Activity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.78: The metals have variable effects on restoring MCP activity to the EDTA-treated complex, but none restores the insulin effect. 

Phrase: "The metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025552:Metals [Inorganic Chemical]
   916 E C2986473:Metallic [Qualitative Concept]

Phrase: "have"

Phrase: "variable effects on restoring MCP activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "to the EDTA-treated complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "but"

Phrase: "none"

Phrase: "restores"

Phrase: "the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.79: However, Zn2+, Ca2+, and Co2+ restore the regulatory function of IDE on MCP activity in the EGTA-treated material. 

Phrase: "However,"

Phrase: "Zn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Co2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "restore"

Phrase: "the regulatory function of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "on MCP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the EGTA-treated material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]
Processing 00000000.tx.80: Manganese appeared to restore insulin sensitivity, but did not reach statistical significance (P = 0.066 in a one-tailed t test). 

Phrase: "Manganese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024706:Manganese [Element, Ion, or Isotope]
  1000   C2348271:MANGANESE [Element, Ion, or Isotope]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restore"

Phrase: "insulin sensitivity,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(P = 0.066 in a one-tailed t test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0022885:Test [Laboratory Procedure]
   742   C0039259:tailed [Body Part, Organ, or Organ Component]
   742   C0039593:Test [Functional Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392366:test [Intellectual Product]
   742   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.81: View larger version (17K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.82: The effect of EDTA treatment and metal readdition on LLVY-degrading activity and its inhibition by insulin. 

Phrase: "The effect of EDTA treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "metal readdition on LLVY-degrading activity"

Phrase: "and"

Phrase: "its inhibition by insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.83: The graph shows the activity of the IDE-MCP complex toward LLVY after various treatments, without (open bars) and with (closed bars) the addition of 1 M insulin. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the activity of the IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   777   C2258865:multicatalytic proteinase activity [Molecular Function]
   757   C0243102:enzyme activity [Molecular Function]
   757   C1145751:insulin activity [Molecular Function]
   757   C1150095:proteinase activity [Molecular Function]
   757   C1622131:proteinase activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "toward LLVY"

Phrase: "after various treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "without"

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(closed bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "the addition of 1 M insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]
Processing 00000000.tx.84: Partially purified IDE-MCP complex was dialyzed overnight against sodium acetate or sodium acetate with 1 mM EDTA, with readdition of various metals. 

Phrase: "Partially purified IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   850   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   836   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2258865:multicatalytic proteinase [Molecular Function]
   793   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0439855:Complex [Qualitative Concept]
   793   C1622131:proteinase [Molecular Function]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1947941:Proteinase [Enzyme]

Phrase: "was"

Phrase: "dialyzed"

Phrase: "overnight against sodium acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0439583:Overnight [Temporal Concept]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "sodium acetate with 1 mM EDTA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   783   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   753   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "with readdition"

Phrase: "of various metals."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]
Processing 00000000.tx.85: Values shown are the mean  SEM of LLVY-degrading activity normalized to the activity of untreated enzyme with no insulin added. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of LLVY-degrading activity"

Phrase: "normalized to the activity of untreated enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0243102:enzyme activity [Molecular Function]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0205177:Activity [Functional Concept]
   748   C0332155:untreated [Finding]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1882115:Normalized [Research Activity]

Phrase: "with no insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.86: The metal chloride concentrations used were those that maximally restored IDE activity toward radiolabeled insulin and were as follows: Zn2+, 10-6 M; 

Phrase: "The metal chloride concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "those"

Phrase: "that maximally restored IDE activity toward radiolabeled insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243102:enzyme activity [Molecular Function]
   757   C1145751:insulin activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Zn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "10-6 M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0439187:/10^6 [Quantitative Concept]
   734   C1881839:10^6 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.87: Ca2+, 10-3 M; 

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "10-3 M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C1883310:10^3 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.88: Mn2+, 5 x 10-6 M; 

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "5 x 10-6 M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]
   708   C0442749:5 6 [Finding]

Phrase: ";"
Processing 00000000.tx.89: and Co2+, 10-5 M.  

Phrase: "and"

Phrase: "Co2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "10-5 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.90: View larger version (19K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.91: The effect of EGTA treatment and metal readdition on LLVY-degrading activity and its inhibition by insulin. 

Phrase: "The effect of EGTA treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "metal readdition on LLVY-degrading activity"

Phrase: "and"

Phrase: "its inhibition by insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.92: The graph shows the activity of the IDE-MCP complex toward LLVY after various treatments without (open bars) and with (closed bars) the addition of 1 M insulin. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the activity of the IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   777   C2258865:multicatalytic proteinase activity [Molecular Function]
   757   C0243102:enzyme activity [Molecular Function]
   757   C1145751:insulin activity [Molecular Function]
   757   C1150095:proteinase activity [Molecular Function]
   757   C1622131:proteinase activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "toward LLVY"

Phrase: "after various treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "without"

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(closed bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "the addition of 1 M insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]
Processing 00000000.tx.93: Partially purified IDE-MCP complex was dialyzed overnight against sodium acetate or sodium acetate with 1 mM EGTA, with readdition of various metals. 

Phrase: "Partially purified IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   850   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   836   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2258865:multicatalytic proteinase [Molecular Function]
   793   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0439855:Complex [Qualitative Concept]
   793   C1622131:proteinase [Molecular Function]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1947941:Proteinase [Enzyme]

Phrase: "was"

Phrase: "dialyzed"

Phrase: "overnight against sodium acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0439583:Overnight [Temporal Concept]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "sodium acetate with 1 mM EGTA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   783   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   753   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "with readdition"

Phrase: "of various metals."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]
Processing 00000000.tx.94: Values shown are the mean  SEM of LLVY-degrading activity normalized to the activity of untreated enzyme with no insulin added. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of LLVY-degrading activity"

Phrase: "normalized to the activity of untreated enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0243102:enzyme activity [Molecular Function]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0205177:Activity [Functional Concept]
   748   C0332155:untreated [Finding]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1882115:Normalized [Research Activity]

Phrase: "with no insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.95: As EGTA treatment had little effect on insulin-degrading activities, the metal concentrations used were the same as those used for the EDTA-treated enzyme: Zn2+, 10-6 M; 

Phrase: "As EGTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "little effect on insulin-degrading activities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "the metal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the same as those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "used for the EDTA-treated enzyme"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1273517:used [Finding]
   753   C1522326:Treated [Functional Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "Zn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "10-6 M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0439187:/10^6 [Quantitative Concept]
   734   C1881839:10^6 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.96: Ca2+, 10-3 M; 

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "10-3 M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C1883310:10^3 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.97: Mn2+, 5 x 10-6 M; 

Phrase: "Mn2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "5 x 10-6 M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]
   708   C0442749:5 6 [Finding]

Phrase: ";"
Processing 00000000.tx.98: and Co2+, 10-5 M.  

Phrase: "and"

Phrase: "Co2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "10-5 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.99: MCP has multiple catalytic sites. 

Phrase: "MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "has"

Phrase: "multiple catalytic sites."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0205681:Sites, Catalytic [Functional Concept]
   867 E C0600499:catalytic site [Amino Acid Sequence]
   827   C0007382:Catalytic [Natural Phenomenon or Process]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.100: Insulin and IDE regulate the trypsin-like (LSTR degradation) as well as the chymotrypsin-like (LLVY degradation) activity. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulate"

Phrase: "the trypsin-like"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(LSTR degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ")"

Phrase: "as well as"

Phrase: "the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(LLVY degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ")"

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.101: EDTA treatment dramatically decreases LSTR degradation and eliminates the insulin effect (Fig. 5). 

Phrase: "EDTA treatment dramatically"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "LSTR degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "eliminates"

Phrase: "the insulin effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: The readdition of the divalent cations, Ca2+ and Co2+, restores some degrading activity, but not the insulin effect. 

Phrase: "The readdition of the divalent cations,"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Co2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "restores"

Phrase: "some degrading activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.103: EGTA treatment reduces LSTR activity, but the change does not achieve significance and does not remove the insulin inhibition of that MCP activity (Fig. 6). 

Phrase: "EGTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "LSTR activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the insulin inhibition of that MCP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.104: View larger version (17K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.105: The effects of EDTA treatment and metal readdition on LSTR-degrading activity and its inhibition by insulin. 

Phrase: "The effects of EDTA treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1518681:Treatment Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "metal readdition on LSTR-degrading activity"

Phrase: "and"

Phrase: "its inhibition by insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.106: See Fig. 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.107: 3 for details.  

Phrase: "3 for details."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0439086:<3 [Quantitative Concept]
   790   C1522508:Details [Qualitative Concept]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.108: View larger version (20K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.109: The effects of EGTA treatment and metal readdition on LSTR-degrading activity and its inhibition by insulin. 

Phrase: "The effects of EGTA treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1518681:Treatment Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "metal readdition on LSTR-degrading activity"

Phrase: "and"

Phrase: "its inhibition by insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.110: See Fig. 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.111: 4 for details.  

Phrase: "4 for details."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522508:Details [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.112: These data ( Figs. 26) support a role for an easily dissociable divalent cation that is essential for the insulin effect on the complex (EGTA effects). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "( Figs. 26"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: ")"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for an easily dissociable divalent cation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "essential for the insulin effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "on the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(EGTA effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.113: EDTA treatment, however, results in more profound alterations, perhaps due to partial removal of a more tightly bound cation and subsequent conformational changes. 

Phrase: "EDTA treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "however,"

Phrase: "results in more profound alterations,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439808:Profound [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "perhaps due to partial removal of a more tightly bound cation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C0678226:Due to [Functional Concept]
           due
   738   C0007447:Cation [Chemical Viewed Structurally]
   738   C0015252:Removal [Therapeutic or Preventive Procedure]
   738   C0332297:bound [Spatial Concept]
   738   C0728938:Partial [Quantitative Concept]
   738   C0728940:Removal [Therapeutic or Preventive Procedure]
   738   C1145667:Bound [Activity]
   738   C1167622:Bound [Molecular Function]
   738   C1550516:partial [Idea or Concept]
   738   C1689898:% bound [Quantitative Concept]
   738   C2349209:Bound [Conceptual Entity]
   738   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "subsequent conformational changes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0301641:Conformational change [Molecular Function]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.114: Simple addition of individual cations did not restore functional control of the complex by insulin. 

Phrase: "Simple addition of individual cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restore"

Phrase: "functional control of the complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.115: To further explore the regulatory role of IDE in control of MCP, selected inhibitors were examined (Table 1). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "explore"

Phrase: "the regulatory role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of MCP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "selected inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: The metalloproteinase inhibitor, 1,10-phenanthroline, inhibited IDE and abolished the insulin effect on LLVY degradation similar to EDTA. 

Phrase: "The metalloproteinase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "abolished"

Phrase: "the insulin effect on LLVY degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "similar to EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.117: N-ethylmaleimide and bacitracin, known inhibitors of IDE, also blocked the effect of insulin. 

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "and"

Phrase: "bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "known inhibitors of IDE,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   783   C0021643:inhibitors insulin [Pharmacologic Substance]
   783   C1152555:enzyme inhibitors [Molecular Function]
   783   C2756995:Enzyme Inhibitors [Molecular Function]
   767 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "also"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.118: Phenylmethylsulfonylfluoride, at low concentrations, had no appreciable effect. 

Phrase: "Phenylmethylsulfonylfluoride,"

Phrase: "at low concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "had"

Phrase: "no appreciable effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.119: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.120: The effects of various inhibitors on the IDE-MCP complex  Table 2 compares the effects of inhibitors of IDE on the proteolytic activity of the IDE-MCP complex and purified MCP. 

Phrase: "The effects of various inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the IDE-MCP complex  Table 2"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   850   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
           Insulin-Degrading Enzyme
   836   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   835   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2258865:multicatalytic proteinase [Molecular Function]
   793   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0039224:Table [Manufactured Object]
   793   C0439855:Complex [Qualitative Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1622131:proteinase [Molecular Function]
   793   C1704241:Complex [Chemical Viewed Structurally]
   793   C1706073:Table [Medical Device]
   793   C1706074:Table [Intellectual Product]
   793   C1947941:Proteinase [Enzyme]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C0014445:enzymes [Functional Concept]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the effects of inhibitors of IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on the proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "of the IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   876   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2258865:multicatalytic proteinase [Molecular Function]
   799   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C0439855:Complex [Qualitative Concept]
   799   C1622131:proteinase [Molecular Function]
   799   C1704241:Complex [Chemical Viewed Structurally]
   799   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "purified MCP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2258865:multicatalytic proteinase [Molecular Function]
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.121: Phenanthroline, N-ethylmaleimide, and bacitracin inhibit LLVY degradation when MCP is complexed with IDE, but these agents are ineffective on purified MCP. 

Phrase: "Phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031370:phenanthroline [Organic Chemical]

Phrase: "N-ethylmaleimide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "LLVY degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "when"

Phrase: "MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "is"

Phrase: "complexed with IDE,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   781   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0439855:Complex [Qualitative Concept]
   726   C1704241:Complex [Chemical Viewed Structurally]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "but"

Phrase: "these agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "ineffective on purified MCP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.122: These findings support a regulatory (activating) effect of IDE on MCP activity. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a regulatory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220905:regulatory [Regulation or Law]
  1000   C1704735:Regulatory [Conceptual Entity]

Phrase: "("

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "effect of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on MCP activity."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.123: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.124: The effects of inhibitors of IDE on MCP activity  The importance of activation of MCP by IDE is supported by the effect of removal of IDE during purification. 

Phrase: "The effects of inhibitors of IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on MCP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "The importance of activation of MCP"

Phrase: "by IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "supported by the effect of removal of IDE"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   741   C0558658:Support removal [Therapeutic or Preventive Procedure]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0015252:Removal [Therapeutic or Preventive Procedure]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0728940:Removal [Therapeutic or Preventive Procedure]
   739   C1280500:Effect [Qualitative Concept]
   739   C1521721:Supported [Conceptual Entity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C2348382:Effect [Qualitative Concept]
   706 E C0183683:Support [Medical Device]

Phrase: "during purification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]
Processing 00000000.tx.125: As reported previously (11, 12), IDE and MCP (LLVY degradation) copurify through various standard and affinity procedures, but can be separated on ion exchange columns. 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(11,"

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "(LLVY degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ")"

Phrase: "copurify through various standard"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "affinity procedures,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "but"

Phrase: "can"

Phrase: "be"

Phrase: "separated on ion exchange columns."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0022013:Ion Exchange [Molecular Function]
   760   C0022023:Ion [Element, Ion, or Isotope]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0678640:exchange [Social Behavior]
   760   C0687118:Separated [Functional Concept]
   760   C1700702:ION [Functional Concept]
   726   C1185738:Column [Body Part, Organ, or Organ Component]
   726   C1706132:Column [Idea or Concept]
Processing 00000000.tx.126: The IDE-MCP complex was purified through ammonium sulfate fractionation, diethylaminoethyl batch separation, phenyl-Sepharose, P200, and chromatofocusing. 

Phrase: "The IDE-MCP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   876   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2258865:multicatalytic proteinase [Molecular Function]
   799   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C0439855:Complex [Qualitative Concept]
   799   C1622131:proteinase [Molecular Function]
   799   C1704241:Complex [Chemical Viewed Structurally]
   799   C1947941:Proteinase [Enzyme]

Phrase: "was"

Phrase: "purified through ammonium sulfate fractionation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   760   C0002611:Ammonium [Inorganic Chemical]
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C1998793:Purified [Functional Concept]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   760   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "diethylaminoethyl batch separation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036679:Separation [Pathologic Function]
   827   C0237868:Separation [Social Behavior]
   827   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "phenyl-Sepharose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0070617:phenyl-sepharose [Carbohydrate]
   861   C0036681:Sepharose [Carbohydrate]
   861   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "P200,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1538920:p200 [Gene or Genome]
  1000   C1540206:p200 [Gene or Genome]
  1000   C2987236:p200 [Gene or Genome]
  1000   C3540624:p200 [Gene or Genome]

Phrase: "and"

Phrase: "chromatofocusing."
Processing 00000000.tx.127: The preparation was then chromatographed on a Mono-Q HPLC column with all LLVY-degrading activity eluting in a sharp, symmetrical peak (not shown). 

Phrase: "The preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "chromatographed on a Mono-Q HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0066715:Mono Q [Biomedical or Dental Material,Organic Chemical]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1551432:Mono [Population Group]
   748   C1551969:Mono [Language]
   748   C1706132:Column [Idea or Concept]
   714   C0302647:chromatograph [Medical Device]

Phrase: "with all LLVY-degrading activity eluting"

Phrase: "in a sharp, symmetrical peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.128: The recovery of LLVY-degrading activity from the ion exchange column was 0.02%, and the specific activity decreased from 6.2 to 1.1 (fluorescent units per g protein/h). 

Phrase: "The recovery of LLVY-degrading activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "from the ion exchange column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
   734   C0022013:Ion Exchange [Molecular Function]

Phrase: "was"

Phrase: "0.02%,"

Phrase: "and"

Phrase: "the specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "decreased from 6.2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 1.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(fluorescent units per g protein/h"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C1706058:Protein Unit [Quantitative Concept]
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.129: IDE control of MCP activity may be due to a conformational change in MCP, as this enzyme is responsive to reagents that alter its conformation (23). 

Phrase: "IDE control of MCP activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   731   C1706449:Active Control [Research Activity]

Phrase: "may"

Phrase: "be due to a conformational change"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0301641:Conformational change [Molecular Function]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "in MCP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "as"

Phrase: "this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "responsive to reagents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205342:Responsive [Functional Concept]
   718 E C2371924:Responsivity [Mental Process]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: SDS at low concentrations increases the activity, with higher concentrations inhibiting (24). 

Phrase: "SDS at low concentrations"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "with higher concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.131: To explore this, dose-response curves with SDS were performed on the IDE-MCP complex without and with insulin, and the effects on LLVY, LSTR, and LLE activities were examined (Fig. 7). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "this,"

Phrase: "dose-response curves with SDS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C0683162:dose-response curve [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
   726   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "performed on the IDE-MCP complex"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
           Insulin Proteinase
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   764   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C2258865:multicatalytic proteinase [Molecular Function]
   762   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0439855:Complex [Qualitative Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1622131:proteinase [Molecular Function]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C1947941:Proteinase [Enzyme]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "without"

Phrase: "and with insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the effects on LLVY,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "LSTR,"

Phrase: "and"

Phrase: "LLE activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.132: LLVY-degrading activity was stimulated by SDS at concentrations between 0.0150.030%. 

Phrase: "LLVY-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "stimulated by SDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "between 0.0150.030%."
Processing 00000000.tx.133: Insulin inhibited LLVY and LSTR, but not LLE, degradation in the absence of SDS, but had no effect or had even a slight stimulatory effect in the presence of SDS. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "LLVY"

Phrase: "and"

Phrase: "LSTR,"

Phrase: "but"

Phrase: "not LLE,"

Phrase: "degradation in the absence of SDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "had"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "had"

Phrase: "even"

Phrase: "a slight stimulatory effect in the presence of SDS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.134: View larger version (16K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.135: Insulin has no effect on peptide degradation by SDS-activated multicatalytic proteinase. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "no effect on peptide degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "by SDS-activated multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2258865:multicatalytic proteinase [Molecular Function]
   812   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1622131:proteinase [Molecular Function]
   812   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.136: Enzyme (ammonium sulfate-purified complex) was incubated with increasing concentrations of SDS (00.035%, wt/vol) in the presence () and absence () of 1 M insulin. 

Phrase: "Enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(ammonium sulfate-purified complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with increasing concentrations of SDS (00.035%,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0086045:Concentrations [Mental Process]
   744   C0442808:Increasing [Functional Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "wt/vol) in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449468:VOL [Quantitative Concept]
   760   C0560268:vol% [Quantitative Concept]
   760   C1690016:% vol [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "("

Phrase: ")"

Phrase: "of 1 M insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.137: Degradation of peptides is expressed as fluorescence liberated (arbitrary units) per 60 min. 

Phrase: "Degradation of peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C1523817:peptide degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "expressed as fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "liberated"

Phrase: "(arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "per 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.138: LLE degradation is expressed as thousands.  

Phrase: "LLE degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "expressed as thousands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883310:Thousand [Quantitative Concept]
Processing 00000000.tx.139: To determine if the insulin effect on the complex could be restored, IDE-MCP was activated by SDS, and then the SDS was removed (Table 3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the insulin effect on the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "restored"

Phrase: ","

Phrase: "IDE-MCP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
           Insulin-Degrading Enzyme
   840   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2258865:multicatalytic proteinase [Molecular Function]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1947941:Proteinase [Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "activated by SDS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the SDS"

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: Degradation of LLVY was monitored continuously, and insulin was added to achieve sequential concentrations of 10-9, 10-8, and 10-6 M. 

Phrase: "Degradation of LLVY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "continuously,"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "sequential concentrations of 10-9,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "10-8,"

Phrase: "and"

Phrase: "10-6 M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0439187:/10^6 [Quantitative Concept]
   734   C1881839:10^6 [Quantitative Concept]
Processing 00000000.tx.141: As can be seen, MCP activity was inhibited at all insulin concentrations after removal of SDS. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: ","

Phrase: "MCP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "inhibited at all insulin concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1446561:Concentration [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "after removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of SDS."
Processing 00000000.tx.142: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.143: Effect of insulin on MCP after treatment and removal of SDS   Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Although a role for IDE in cellular insulin metabolism is firmly established (7), many factors mitigate against this being the sole physiological activity of the enzyme. 

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "removal of SDS   Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015252:Removal [Therapeutic or Preventive Procedure]
   744   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "a role for IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in cellular insulin metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1524026:cellular metabolism [Cell Function]
   901   C3547575:insulin metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "firmly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880776:Firmly [Qualitative Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "many factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "mitigate against this"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1553901:Mitigate [Idea or Concept]
   734 E C0205081:Moderate [Qualitative Concept]
   734 E C1881878:Moderate [Qualitative Concept]

Phrase: "being"

Phrase: "the sole physiological activity of the enzyme."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0243102:enzyme activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.144: Although all of insulin-sensitive tissues contain the enzyme, it is also found in noninsulin-sensitive tissues and in multiple subcellular compartments. 

Phrase: "Although"

Phrase: "all of insulin-sensitive tissues"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   797   C2983684:ALL TISSUES [Body Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0040300:Tissues [Tissue]
   760   C0332324:Sensitive [Functional Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1550474:sensitive [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3539085:All [Idea or Concept]
   726 E C1547928:Tissue [Intellectual Product]
   723   C0920563:Insulin Sensitivity [Pathologic Function]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "found in noninsulin-sensitive tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040300:Tissues [Tissue]
   760   C0150312:Found [Quantitative Concept]
   760   C0332324:Sensitive [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]
   726 E C0243095:Find [Finding]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "and in multiple subcellular compartments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439064:Multiple [Quantitative Concept]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C1515981:And [Idea or Concept]
   726 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.145: IDE is found in peroxisomes (25, 26, 27), cytosol (7), and endosomes (28) and on plasma membranes (29). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "found in peroxisomes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C0752063:Peroxisomes [Cell Component]
   756 E C0243095:Find [Finding]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "(25,"

Phrase: "26,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(28"

Phrase: ")"

Phrase: "and on plasma membranes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0007603:Plasma Membranes [Cell Component]
   770   C0025255:Membranes [Tissue]
   770   C0032105:Plasma [Body Substance]
   770   C1515981:And [Idea or Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.146: The cellular content of IDE is developmentally regulated, and IDE has been implicated in cellular differentiation (26, 30, 31, 32) and in growth factor binding (30). 

Phrase: "The cellular content of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "developmentally"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "and"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in cellular differentiation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   770   C0007589:Differentiation [Cell Function]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "(26,"

Phrase: "30,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "in growth factor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1149299:Growth Factor Binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.147: These diverse properties become less confusing if IDE is recognized as a multifunctional protein that can complex with a variety of subcellular components (proteasome, steroid receptor, and peroxisomes) and alter the activities of these complexes. 

Phrase: "These diverse properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "become"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "confusing"

Phrase: "if"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "recognized as a multifunctional protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "can"

Phrase: "complex with a variety of subcellular components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "steroid receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034840:Steroid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0038317:Steroid [Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the activities of these complexes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.148: The stimulatory effects of IDE on proteasomes and the glucocorticoid and androgen receptors are established by the present and previous reports (9, 12), but the mechanism is not. 

Phrase: "The stimulatory effects of IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "the glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "and"

Phrase: "androgen receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0034786:Receptors, Androgen [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "are"

Phrase: "established by the present"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0443211:Established [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1272684:Established [Qualitative Concept]

Phrase: "and"

Phrase: "previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(9,"

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.149: The reversible nature of the activation argues against proteolytic activation of the complex by IDE. 

Phrase: "The reversible nature of the activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "argues against proteolytic activation of the complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C2249699:activation of proteolysis [Molecular Function]
   748   C0439855:Complex [Qualitative Concept]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1879547:Activation [Activity]
   748   C1947941:proteolytic [Enzyme]

Phrase: "by IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.150: Other possibilities include conformational changes in the complex, IDE degradation of the ligand, proteolytic products generated by IDE, or some combination of these. 

Phrase: "Other possibilities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   916   C0332149:Possible [Qualitative Concept]
   916   C1705910:Possible [Qualitative Concept]
   916   C2362652:Possible [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "conformational changes in the complex,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0301641:Conformational change [Molecular Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "IDE degradation of the ligand,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0678637:enzyme degradation [Laboratory Procedure]
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "proteolytic products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "generated by IDE,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3146294:Generated [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "some combination of these."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]
Processing 00000000.tx.151: The present study provides evidence that divalent cations are involved in the activity and control of the IDE-MCP complex. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that divalent cations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "involved in the activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "control of the IDE-MCP complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.152: Treatment of the partially purified enzyme with EDTA significantly reduced the activity of IDE, which can be restored by the addition of Ca2+ with as little as 10-6 M. 

Phrase: "Treatment of the partially purified enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with EDTA significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the activity of IDE,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0243102:enzyme activity [Molecular Function]
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "restored by the addition of Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1883712:Addition [Functional Concept]

Phrase: "with"

Phrase: "as"

Phrase: "little as 10-6 M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   760   C0700321:Little [Quantitative Concept]
   760   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.153: This effect is presumably mediated by removal of the Zn2+ found at the active site of IDE, which is required for activity. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "presumably"

Phrase: "mediated by removal of the Zn2+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]
   753   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "found at the active site of IDE,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   764   C0205681:Active Site [Functional Concept]
   764   C2945843:Site of [Qualitative Concept]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0150312:Found [Quantitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0205177:Active [Functional Concept]
   742   C1515974:Site [Body Location or Region]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2825164:Site [Spatial Concept]
   708 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "required for activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1514873:Required [Functional Concept]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.154: This treatment also reduces the chymotrypsin-like and trypsin-like activities of the proteasome and eliminates the ability of insulin to inhibit these activities. 

Phrase: "This treatment also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities of the proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1150284:trypsin activity [Molecular Function]
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "eliminates"

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "these activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.155: The addition of Ca2+ or Co2+ restores the chymotrypsin-like and trypsin-like activities, but fails to restore the insulin responsiveness. 

Phrase: "The addition of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "Co2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "restores"

Phrase: "the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C1150284:trypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restore"

Phrase: "the insulin responsiveness."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]
Processing 00000000.tx.156: Zn2+ and Mn2+ show relatively little effect. 

Phrase: "Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "Mn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "relatively little effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.157: We also examined the effect of EGTA on the complex. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of EGTA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.158: EGTA has a slightly higher affinity (2.5 times) for Ca2+ than does EDTA, but has 1010,000 times less affinity for other cations (including Zn2+) (21). 

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "has"

Phrase: "a slightly higher affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(2.5 times"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: ")"

Phrase: "for Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "than"

Phrase: "does"

Phrase: "EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "has"

Phrase: "1010,"

Phrase: "000 times less affinity for other cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: ")"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.159: Under the conditions of these experiments, EGTA had no effect on IDE activity (data not shown), but did reduce the chymotrypsin-like activity of the proteasome and effectively eliminated the insulin effect. 

Phrase: "Under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "had"

Phrase: "no effect on IDE activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "did"

Phrase: "reduce"

Phrase: "the chymotrypsin-like activity of the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1150252:chymotrypsin activity [Molecular Function]
   774   C1622946:proteasome activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effectively"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.160: A similar reduction was seen with trypsin-like activity, although it did not reach statistical significance. 

Phrase: "A similar reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "seen with trypsin-like activity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C1150284:trypsin activity [Molecular Function]
   760   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "although"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.161: Insulins ability to inhibit was restored by some of the cations (Ca2+ and Co2+). 

Phrase: "Insulins ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "was"

Phrase: "restored by some of the cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "(Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Co2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.162: These data suggest that there are two metals involved in the complex, as we have reported previously (15). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "two metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "involved in the complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as"

Phrase: "we"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.163: We propose that one metal, zinc, is tightly bound to IDE, and is essential for its activity, and the other, possibly Mn2+ or Ca2+, is more loosely bound and is required for the productive interaction of IDE and the proteasome. 

Phrase: "We"

Phrase: "propose"

Phrase: "that one metal,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metal [Inorganic Chemical]
   789 E C2986473:Metallic [Qualitative Concept]

Phrase: "zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "tightly"

Phrase: "bound to IDE,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   797   C1317461:Insulin.bound [Laboratory or Test Result]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "essential for its activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "the other,"

Phrase: "possibly Mn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "or"

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "more loosely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "required for the productive interaction of IDE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   762   C3537101:Enzyme Interaction [Molecular Function]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1514873:Required [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.164: EDTA can chelate the tightly bound Zn2+ and the more loosely bound metal associated with the complex. 

Phrase: "EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "chelate"

Phrase: "the tightly bound Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "the more loosely bound metal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0025552:Metal [Inorganic Chemical]
   741 E C2986473:Metallic [Qualitative Concept]

Phrase: "associated with the complex."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.165: This inhibits IDE, thereby lessening its stimulatory effect on the proteasome. 

Phrase: "This"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "thereby lessening"

Phrase: "its stimulatory effect on the proteasome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.166: Loss of the Zn2+ molecule causes a conformational change in IDE, dissociating it from the proteasome and disrupting the ability of insulin to alter proteasome activity. 

Phrase: "Loss of the Zn2+ molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a conformational change in IDE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0301641:Conformational change [Molecular Function]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "dissociating"

Phrase: "it from the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "proteasome activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.167: Readdition of divalent cation restores IDE activity, but because it is no longer part of the complex, IDE cannot alter proteasome function. 

Phrase: "Readdition of divalent cation"

Phrase: "restores"

Phrase: "IDE activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C1145751:insulin activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "but"

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "no longer part of the complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cannot"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "proteasome function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.168: However, EGTA only has effects on the more loosely bound metal and disrupts IDEs ability to affect chymotrypsin-like activity, but does not cause IDE to dissociate from the complex. 

Phrase: "However,"

Phrase: "EGTA only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "has"

Phrase: "effects on the more loosely bound metal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IDEs ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "chymotrypsin-like activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1150252:chymotrypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "dissociate from the complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.169: Thus, addition of cations can restore insulin sensitivity. 

Phrase: "Thus,"

Phrase: "addition of cations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "can"

Phrase: "restore"

Phrase: "insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.170: The fact that IDE must be active and in a complex with the proteasome to mediate its regulatory effects is further supported by the data presented in Tables 1 and 2. 

Phrase: "The fact"

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "must"

Phrase: "be"

Phrase: "active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: "and in a complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with the proteasome to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "its regulatory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the data"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C3245479:data [Medical Device]
   737 E C0183683:Support [Medical Device]

Phrase: "presented in Tables 1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0039224:tables [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706074:Tables [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
   737 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.171: Agents that inhibit IDE lessen proteasome activity and effectively eliminate insulins inhibitory effect. 

Phrase: "Agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "lessen"

Phrase: "proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effectively"

Phrase: "eliminate"

Phrase: "insulins inhibitory effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.172: Finally, we studied the IDE proteasome interactions using SDS, which has been shown to alter proteasome conformation. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the IDE proteasome interactions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   853   C1373066:Enzyme Interactions [Molecular Function]
   836 E C3537101:Enzyme Interaction [Molecular Function]
   823   C1514525:Proteasome Interaction [Molecular Function]
   771   C1704675:Interaction [Functional Concept]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SDS,"

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "proteasome conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.173: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: 7, the chymotrypsin and trypsin-like activities of the proteasome are insulin sensitive in the absence of SDS, but lose both sensitivity and considerable activity at 0.005% SDS. 

Phrase: "7,"

Phrase: "the chymotrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities of the proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1150284:trypsin activity [Molecular Function]
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "insulin sensitive in the absence of SDS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0332324:Sensitive [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550474:sensitive [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "but"

Phrase: "lose"

Phrase: "both sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "considerable activity at 0.005% SDS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.175: Presumably, this is due to SDS altering the interaction between IDE and the proteasome. 

Phrase: "Presumably,"

Phrase: "this"

Phrase: "is due to SDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678226:Due to [Functional Concept]
           due
   770   C3146286:Due [Idea or Concept]

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the interaction between IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C3537101:Enzyme Interaction [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.176: At higher concentrations, SDS further alters the conformation of the proteasome and stimulates the chymotrypsin-like and peptidyl glutamyl-degrading activities. 

Phrase: "At higher concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "SDS further"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the conformation of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "stimulates"

Phrase: "the chymotrypsin-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413809:chymotrypsin-like [Gene or Genome]
   861   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "peptidyl glutamyl-degrading activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.177: However, at these high concentrations, IDE is still unable to interact with the proteasomes, and insulin does not inhibit. 

Phrase: "However,"

Phrase: "at these high concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "still unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1299582:Unable [Finding]

Phrase: "interact with the proteasomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C1325620:proteasome [Cell Component]
   737 E C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.178: This effect is reversible. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "reversible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]
Processing 00000000.tx.179: The data presented here characterize and further support the idea that IDE can serve as a regulator of the proteasome. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "characterize"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "serve as a regulator of the proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0182953:REGULATOR [Medical Device]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1325620:proteasome [Cell Component]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
   748   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.180: Metal ions play important roles in this interaction. 

Phrase: "Metal ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in this interaction."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.181: First, IDE is a metalloproteinase and must be active for insulins inhibitory effect. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "must"

Phrase: "be"

Phrase: "active for insulins inhibitory effect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205177:Active [Functional Concept]
Processing 00000000.tx.182: Further, a second, more loosely bound divalent cation is required for IDE to mediate its effects. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "a second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "more loosely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "divalent cation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:divalent cation [Chemical Viewed Structurally]
   861   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "required for IDE to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1514873:Required [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "its effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.183: Changes in protein conformation are important, as illustrated by the loss of activity when IDE has its active site metal removed, and by changes in activity induced by SDS. 

Phrase: "Changes in protein conformation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   767   C0301641:Conformational change [Molecular Function]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "important,"

Phrase: "as"

Phrase: "illustrated by the loss of activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1517945:Loss [Quantitative Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "its active site metal"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025552:Metal [Inorganic Chemical]
   755 E C2986473:Metallic [Qualitative Concept]
   734   C0205681:Active Site [Functional Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "induced by SDS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.184: The physiological effect of insulin is to inhibit cellular protein degradation, with greater effects during catabolic states (e.g. starvation, diabetes, and traumatic stress). 

Phrase: "The physiological effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cellular protein degradation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1523944:cellular protein degradation [Cell Function]
   913   C1523935:cellular degradation [Cell Function]
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "with greater effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "during catabolic states"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0853892:catabolic state [Disease or Syndrome]
   861   C0311402:catabolic [Functional Concept]
   861   C1301808:states [Geographic Area]
   861   C1516314:Catabolic [Physiologic Function]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "("

Phrase: "e.g. starvation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038187:Starvation [Finding]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "traumatic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ")."
Processing 00000000.tx.185: As cell survival requires continued protein turnover, it would not be expected that insulin could totally inhibit MCP activity or completely block protein degradation. 

Phrase: "As cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "requires"

Phrase: "continued protein turnover,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597297:Protein Turnover [Molecular Function]
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]

Phrase: "it"

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "totally"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MCP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2258865:multicatalytic proteinase activity [Molecular Function]
           multicatalytic proteinase
   901   C1150095:proteinase activity [Molecular Function]
   901   C1622131:proteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "protein degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.186: Rather, the IDE-MCP interaction may serve as an activator of basal cellular protein degradation, analogous to activation of the glucocorticoid and androgen receptors by IDE (9), with insulin and other substrates then acting to inhibit the stimulated process. 

Phrase: "Rather,"

Phrase: "the IDE-MCP interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3537101:Enzyme Interaction [Molecular Function]
   799   C1704675:Interaction [Functional Concept]
   709   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "serve as an activator of basal cellular protein degradation,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1523944:cellular protein degradation [Cell Function]
   764   C0597297:Protein Degradation [Molecular Function]
   764   C0597304:Protein Degradation [Molecular Function]
   764   C1623036:Protein Degradation [Molecular Function]
   762   C1523935:cellular degradation [Cell Function]
   742   C0007634:Cellular [Cell]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178539:Cellular [Functional Concept]
   742   C0205112:Basal [Spatial Concept]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "analogous to activation of the glucocorticoid"

Phrase: "and"

Phrase: "androgen receptors by IDE"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0034786:Receptors, Androgen [Amino Acid, Peptide, or Protein,Receptor]
   783   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   767 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   756 E C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0002844:Androgen [Hormone,Pharmacologic Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "other substrates then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the stimulated process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.187: Thus, selective effects on cellular protein degradation in insulin-sensitive cells are under the control of insulin-IDE interactions. 

Phrase: "Thus,"

Phrase: "selective effects on cellular protein degradation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in insulin-sensitive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are under the control of insulin-IDE interactions."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   777   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   777   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C1373066:Enzyme Interactions [Molecular Function]
   743 E C3537101:Enzyme Interaction [Molecular Function]
   741   C1707503:Control Interaction [Molecular Function]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0243148:control [Qualitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1550141:Control [Substance]
   739   C1551058:Are [Quantitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]
   706   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.188: MCP comprises a relatively large proportion of the protein in many cells (up to 1%), and IDE, although expressed at high levels in some tissues (33), is not present in sufficient quantities in all tissues to be a universal regulator of all of MCPs activities. 

Phrase: "MCP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a relatively large proportion of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709707:Proportion [Quantitative Concept]

Phrase: "in many cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "up to 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "although"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in some tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in sufficient quantities"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   816   C1699029:Sufficient Quantity [Quantitative Concept]
   816   C1883214:Sufficient Quantity [Qualitative Concept]
   770   C0150312:Present [Quantitative Concept]
   770   C0205410:Sufficient [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1265611:QUANTITIES [Quantitative Concept]
   737 E C1554108:Quantity [Intellectual Product]
   737 E C1561573:Quantity [Intellectual Product]

Phrase: "in all tissues to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "be"

Phrase: "a universal regulator of all of MCPs activities."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0182953:REGULATOR [Medical Device]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.189: Our results show that insulin substantially inhibits only two of the activities of MCP, the chymotrypsin- and trypsin-like activities. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin substantially"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "only two of the activities of MCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205448:Two [Quantitative Concept]

Phrase: "the chymotrypsin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "trypsin-like activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C1150284:trypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.190: The proteasome may have as many as five different proteolytic activities (34). 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "may"

Phrase: "have as many as five different proteolytic activities"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0205451:Five [Quantitative Concept]
   744   C0441655:Activities [Activity]
   744   C0597304:Proteolytic [Molecular Function]
   744   C1705242:Different [Qualitative Concept]
   744   C1947941:proteolytic [Enzyme]
   744   C3154893:Have [Idea or Concept]
   744   C3539897:Have [Qualitative Concept]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.191: It also remains to be determined whether the degradation of ubiquitinylated proteins is inhibited by insulin through IDE. 

Phrase: "It also"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "the degradation of ubiquitinylated proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0597297:Protein Degradation [Molecular Function]
   781   C0597304:Protein Degradation [Molecular Function]
   781   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "through IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.192: Although not widely appreciated, many studies have shown biological activity of intracellular insulin (35, 36) and alterations in insulin activity with inhibition of cellular insulin processing (37, 38). 

Phrase: "Although"

Phrase: "not widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "appreciated"

Phrase: ","

Phrase: "many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "biological activity of intracellular insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1145751:insulin activity [Molecular Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205177:Activity [Functional Concept]
   760   C0205460:biological [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(35,"

Phrase: "36"

Phrase: ")"

Phrase: "and"

Phrase: "alterations in insulin activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0184517:Activity alteration [Finding]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "with inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of cellular insulin processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1158354:insulin processing [Molecular Function]
   827   C1709694:Processing [Activity]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.193: Our recent studies have provided a potential mechanism for these previously unexplained observations. 

Phrase: "Our recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a potential mechanism for these previously unexplained observations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.194: In this scheme, the IDE portion of the complex acts as an intracellular receptor for insulin and possibly other growth factors. 

Phrase: "In this scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: "the IDE portion of the complex acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449719:Portion [Spatial Concept]

Phrase: "as an intracellular receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "other growth factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.195: The insulin-IDE interaction then alters activity of the protein complex (i.e. MCP, glucocorticoid receptor, androgen receptor, and perhaps others) and contributes to the biological actions of insulin. 

Phrase: "The insulin-IDE interaction then"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3537101:Enzyme Interaction [Molecular Function]
   799   C1704675:Interaction [Functional Concept]
   700   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   700   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "activity of the protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1537044:protein activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(i.e. MCP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2258865:multicatalytic proteinase [Molecular Function]
   812   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1622131:proteinase [Molecular Function]
   812   C1947941:Proteinase [Enzyme]

Phrase: "glucocorticoid receptor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034809:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
  1000   C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "androgen receptor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "perhaps others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "contributes to the biological actions of insulin."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205460:biological [Qualitative Concept]
   748   C0441472:actions [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880177:Contribute [Activity]
   714 E C3266814:Action [Activity]
Processing 00000000.tx.196: The insulin effect on MCP can be prevented by altering the activity of IDE. 

Phrase: "The insulin effect on MCP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the activity of IDE."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0243102:enzyme activity [Molecular Function]
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.197: Although speculative, cellular activity regulated by the IDE complexes may be affected by cellular redox state and divalent cation distribution due to changes in IDE. 

Phrase: "Although"

Phrase: "speculative, cellular activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "regulated by the IDE complexes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704241:Complexes [Chemical Viewed Structurally]
   745   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "affected by cellular redox state"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0030012:redox state [Molecular Function]
           Redox
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1301808:State [Geographic Area]
   760   C1314939:Affected [Functional Concept]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "divalent cation distribution due to changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.198: Alterations in insulin action have been associated with ion flux and redistribution and with redox state. 

Phrase: "Alterations in insulin action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "associated with ion flux"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0022023:Ion [Element, Ion, or Isotope]
   770   C1700702:ION [Functional Concept]
   770   C2348693:Flux [Natural Phenomenon or Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "redistribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332620:Redistribution [Functional Concept]

Phrase: "and with redox state."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0030012:redox state [Molecular Function]
           Redox
   770   C1301808:State [Geographic Area]
   770   C1442792:State [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C3148680:State [Geographic Area]
Processing 00000000.tx.199: These effects could be explained in part by regulatory effects of IDE. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "explained in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by regulatory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.200: Further studies are required.  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.201: Acknowledgments  The authors thank Janet Corr for preparation of the manuscript.  

Phrase: "Acknowledgments"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Janet Corr for preparation of the manuscript."
Processing 00000000.tx.202: Footnotes  1 This work was supported by the Department of Veterans Affairs Research Service and the Bly Memorial Research Fund. 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Department of Veterans Affairs"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   853   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   778   C1549054:Veterans Affairs [Organization]
   748   C0042610:Veterans [Population Group]
   748   C1521721:Supported [Conceptual Entity]
   748   C1704729:Department [Organization]
   714 E C0183683:Support [Medical Device]
   714 E C3245459:veteran [Intellectual Product]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557854:Service [Occupational Activity]
  1000   C2825316:Service [Manufactured Object]
  1000   C3245478:service [Idea or Concept]

Phrase: "and"

Phrase: "the Bly Memorial Research Fund."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]
Processing 00000000.tx.203: Received February 25, 1998.  

Phrase: "Received February 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1998."
Processing 00000000.tx.204: References Top Abstract Introduction Materials and Methods Results Discussion References  Duckworth WC, Hamel FG, Bennett RG, Ryan MP, Roth RA 1990 Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Ryan MP,"

Phrase: "Roth RA 1990 Human red blood cell insulin-degrading enzyme"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   855   C0427507:red blood cell enzyme [Laboratory Procedure]
   847   C0443773:Red cell enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   835   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   821   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   821   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   813   C0853230:blood insulin [Laboratory Procedure]
   790   C0014442:Enzyme [Enzyme,Organic Chemical]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C0014445:enzymes [Functional Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "rat skeletal muscle insulin protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0055673:skeletal muscle protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]
   717   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "antigenic sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "generate"

Phrase: "identical products from insulin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.205: J Biol Chem 265:29842987[Abstract/Free FullText] Authier F, Posner BI, Bergeron JJM 1996 Insulin-degrading enzyme. 

Phrase: "J Biol Chem 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "29842987"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1996 Insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.206: Clin Invest Med 19:149160[Medline] Roth RA, Mesirow ML, Yokono K, Baba S 1984 Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. 

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "Med 19"

Phrase: ":"

Phrase: "149160"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roth RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Mesirow ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Yokono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Baba S 1984 Degradation of insulin-like growth factors I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C3547574:insulin degradation [Molecular Function]
   739   C0243125:degradation [Functional Concept]
   739   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "II by a human insulin degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   746   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.207: Endocr Res 10:101112[Medline] Muller D, Baumeister H, Buck F, Richter D 1991 Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. 

Phrase: "Endocr Res 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "101112"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muller D,"

Phrase: "Baumeister H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Buck F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Richter D 1991 Atrial natriuretic peptide (ANP)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   827   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   799   C0018792:Atrial [Body Part, Organ, or Organ Component]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0597421:natriuretic [Pharmacologic Substance]
   727 E C0524422:atria [Body Part, Organ, or Organ Component]
   727 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a high-affinity substrate for rat insulin-degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0178623:enzyme substrate [Chemical Viewed Functionally]
   742   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.208: Eur J Biochem 202:285292[Abstract] Hamel FG, Gehm BD, Rosner RG, Duckworth WC 1997 Identification of the cleavage sites of transforming growth factor- by insulin degrading enzymes. 

Phrase: "Eur J Biochem 202"

Phrase: ":"

Phrase: "285292"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Gehm BD,"

Phrase: "Rosner RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC 1997 Identification of the cleavage sites of transforming growth factor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0020792:Identification [Mental Process]
   736   C0205396:Identification [Qualitative Concept]

Phrase: "by insulin degrading enzymes."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.209: Biochim Biophys Acta 1338:207214[Medline] Duckworth WC, Hamel FG, Peavy DE, Liepnieks JJ, Ryan MP, Hermodson MA, Frank BH 1988 Degradation products of insulin generated by hepatocytes and by insulin protease. 

Phrase: "Biochim Biophys Acta 1338"

Phrase: ":"

Phrase: "207214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Liepnieks JJ,"

Phrase: "Ryan MP,"

Phrase: "Hermodson MA,"

Phrase: "Frank BH 1988 Degradation products of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "generated by hepatocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0227525:Hepatocytes [Cell]
   790   C3146294:Generated [Activity]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and by insulin protease."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1947941:Protease [Enzyme]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.210: J Biol Chem 263:18261833[Abstract/Free FullText] Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "18261833"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC 1988 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.211: Endocr Rev 9:319345[Abstract] Garcia JV, Stoppelli MP, Thompson KL, Decker SJ, Rosner MR 1987 Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors. 

Phrase: "Endocr Rev 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "319345"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Garcia JV,"

Phrase: "Stoppelli MP,"

Phrase: "Thompson KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Decker SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Rosner MR 1987 Characterization of a Drosophila protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "both epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "and"

Phrase: "insulin-related growth factors."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   988   C0063681:insulin-related growth factor [Amino Acid, Peptide, or Protein]
           insulin-related factor
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.212: J Cell Biol 105:449456[Abstract] Kupfer S, Marschke K, Wilson E, French F 1993 Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. 

Phrase: "J Cell Biol 105"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "449456"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kupfer S,"

Phrase: "Marschke K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wilson E,"

Phrase: "French F 1993 Receptor accessory factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C0015435:F Factor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "specific DNA binding of androgen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1148673:DNA Binding [Genetic Function]
   797   C1148623:androgen binding [Molecular Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "glucocorticoid receptors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.213: J Biol Chem 268:1751917527[Abstract/Free FullText] Kupfer SR, Wilson EM, French FS 1994 Androgen and glucocorticoid receptors interact with insulin degrading enzyme. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1751917527"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kupfer SR,"

Phrase: "Wilson EM,"

Phrase: "French FS 1994 Androgen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002844:Androgen [Hormone,Pharmacologic Substance]
   812   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interact with insulin degrading enzyme."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.214: J Biol Chem 269:2062220628[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1994 Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2062220628"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1994 Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020792:Identification [Mental Process]
   812   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "isolation of a cytosolic proteolytic complex containing insulin degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "the multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.215: Biochem Biophys Res Commun 202:10471053[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1994 A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. 

Phrase: "Biochem Biophys Res Commun 202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "10471053"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "A direct inhibitory effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on a cytosolic proteolytic complex containing insulin-degrading enzyme"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   877   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1947941:Proteolytic Enzyme [Enzyme]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.216: J Biol Chem 269:2457524580[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2457524580"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "of the insulin-degrading enzyme-proteasome complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.217: Diabetes 46:197203[Abstract] Hamel F, Bennett R, Harmon K, Duckworth W 1997 Insulin inhibition of proteasome activity in intact cells. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "197203"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hamel F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bennett R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Harmon K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Duckworth W 1997 Insulin inhibition of proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in intact cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: Biochem Biophys Res Commun 234:671674[CrossRef][Medline] Ebrahim A, Hamel FG, Bennett RG, Duckworth WC 1991 Identification of the metal associated with the insulin degrading enzyme. 

Phrase: "Biochem Biophys Res Commun 234"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "671674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ebrahim A,"

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC 1991 Identification of the metal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "associated with the insulin degrading enzyme."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.219: Biochem Biophys Res Commun 181:13981406[Medline] Ryan MP, Duckworth WC 1983 Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease. 

Phrase: "Biochem Biophys Res Commun 181"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "13981406"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ryan MP,"

Phrase: "Duckworth WC 1983 Partial characterization of an endogenous inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "of a calcium-dependent form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "of insulin protease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.220: Biochem Biophys Res Commun 116:195203[Medline] Ryan MP, Gifford JD, Solomon SS, Duckworth WC 1985 The calcium dependence of insulin degradation by rat skeletal muscle. 

Phrase: "Biochem Biophys Res Commun 116"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "195203"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ryan MP,"

Phrase: "Gifford JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Solomon SS,"

Phrase: "Duckworth WC 1985"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013123:WC [Organism Function]
   827   C2825512:WC [Quantitative Concept]

Phrase: "The calcium dependence of insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "by rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.221: Endocrinology 117:16931698[Abstract] Pershadsingh H, Shade D, Delfert D, McDonald J 1987 Chelation of intracellular calcium blocks insulin action in the adipocyte. 

Phrase: "Endocrinology 117"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "16931698"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pershadsingh H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shade D,"

Phrase: "Delfert D,"

Phrase: "McDonald J 1987 Chelation of intracellular calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3537131:Chelation [Molecular Function]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin action in the adipocyte."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.222: Proc Natl Acad Sci USA 84:10251029[Abstract] Frank BH, Peavy DE, Hooker CS, Duckworth WC 1983 Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "10251029"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Hooker CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Duckworth WC 1983 Receptor binding properties of monoiodotyrosyl insulin isomers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]

Phrase: "purified by high performance liquid chromatography."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   882   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   882   C1579831:High performance liquid chromatography [Functional Concept]
   790   C0008565:Liquid Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205250:High [Qualitative Concept]
   753   C0302908:Liquid [Substance]
   753   C0597198:Performance [Individual Behavior]
   753   C1299351:High [Qualitative Concept]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1882330:Performance [Activity]
   753   C1998793:Purified [Functional Concept]
   753   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.223: Diabetes 32:705711[Medline] Duckworth W, Heinemann M, Kitabchi A 1972 Purification of insulin specific protease by affinity chromatography. 

Phrase: "Diabetes 32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "705711"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth W,"

Phrase: "Heinemann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kitabchi"

Phrase: "A 1972 Purification of insulin specific protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243114:purification [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "by affinity chromatography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   761 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.224: Proc Natl Acad Sci USA 69:36983702[Abstract] Blanchard J 1984 Buffers for enzymes. 

Phrase: "Proc Natl Acad Sci USA 69"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0450388:69 [Intellectual Product]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "36983702"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blanchard J 1984 Buffers for enzymes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.225: Methods Enzymol 104:404414[Medline] Duckworth W, Heinemann M, Kitabchi A 1975 Proteolytic degradation of insulin and glucagon. 

Phrase: "Methods Enzymol 104"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "404414"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth W,"

Phrase: "Heinemann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kitabchi"

Phrase: "A 1975 Proteolytic degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.226: Biochim Biophys Acta 377:421430[Medline] Saitoh Y, Yokusawa H, Ishii S 1989 Sodium dodecyl sulfate-induced conformational and enzymatic changes of multicatalytic proteinase. 

Phrase: "Biochim Biophys Acta 377"

Phrase: ":"

Phrase: "421430"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Saitoh Y,"

Phrase: "Yokusawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ishii S 1989 Sodium dodecyl sulfate-induced conformational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   721   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "enzymatic changes of multicatalytic proteinase."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.227: Biochem Biophys Res Commun 162:334339[Medline] Arribas J, Castano J 1990 Kinetic studies of differential effect of detergents on the peptidase activities of the multicatalytic proteinase from rat liver. 

Phrase: "Biochem Biophys Res Commun 162"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "334339"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arribas J,"

Phrase: "Castano J 1990 Kinetic studies of differential effect of detergents"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0022702:kinetic [Natural Phenomenon or Process]
   739   C0947630:studies [Laboratory Procedure]
   706 E C0557651:Study [Manufactured Object]
   706 E C2603343:Study [Research Activity]

Phrase: "on the peptidase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150095:peptidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "of the multicatalytic proteinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "from rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.228: J Biol Chem 265:1396913973[Abstract/Free FullText] Authier F, Bergeron JJ, Ou WJ, Rachubinski RA, Posner BI, Walton PA 1995 Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. 

Phrase: "J Biol Chem 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1396913973"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bergeron JJ,"

Phrase: "Ou WJ,"

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Walton PA 1995 Degradation of the cleaved leader peptide of thiolase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1523817:peptide degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]

Phrase: "by a peroxisomal proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.229: Proc Natl Acad Sci USA 92:38593863[Abstract/Free FullText] Kuo WL, Gehm BD, Rosner MR, Li W, Keller G 1994 Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. 

Phrase: "Proc Natl Acad Sci USA 92"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "38593863"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo WL,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Li W,"

Phrase: "Keller G 1994 Inducible expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cellular localization of insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in a stably transfected cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.230: J Biol Chem 269:2259922606[Abstract/Free FullText] Rabkin R, Birn H, Shi J, Roth R, Christensen E 1992 Insulin degrading enzyme (IDE) in renal proximal tubules. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2259922606"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rabkin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Birn H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shi J,"

Phrase: "Roth R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Christensen E 1992 Insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in renal proximal tubules."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0022674:renal tubules [Body Part, Organ, or Organ Component]
   901   C0022677:proximal tubules [Body Part, Organ, or Organ Component]
   896 E C1283878:Renal tubule [Body Part, Organ, or Organ Component]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0205107:Proximal [Spatial Concept]
Processing 00000000.tx.231: Diabetes 41:15A Hamel FG, Mahoney MJ, Duckworth WC 1991 Degradation of intraendosomal insulin by insulin degrading enzyme without acidification. 

Phrase: "Diabetes 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15A Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "Mahoney MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Duckworth WC 1991 Degradation of intraendosomal insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.232: Diabetes 40:436443[Abstract] Roth R, Mesirow M, Cassell D, Yokono K, Baba S 1985 Characterization of an insulin degrading enzyme from cultured human lymphocytes. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "436443"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roth R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mesirow M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cassell D,"

Phrase: "Yokono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Baba S 1985 Characterization of an insulin degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "from cultured human lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.233: Diabetes Res Clin Pract 1:3139[Medline] Gehm BD, Rosner MR 1991 Regulation of insulin, epidermal growth factor, and transforming growth factor- levels by growth factor degrading enzymes. 

Phrase: "Diabetes Res Clin Pract 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C1315013:CLIN [Intellectual Product]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "3139"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gehm BD,"

Phrase: "Rosner MR 1991 Regulation of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "epidermal growth factor,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "and"

Phrase: "transforming growth factor- levels by growth factor degrading enzymes."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0014440:enzymes levels [Laboratory Procedure]
   762   C1287349:enzymes levels [Laboratory or Test Result]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.234: Endocrinology 128:16031609[Abstract] Kayalar C, Wong WT, Hendrickson L 1990 Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors. 

Phrase: "Endocrinology 128"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "16031609"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kayalar C,"

Phrase: "Wong WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Hendrickson L 1990 Differentiation of BC3H1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "primary skeletal muscle cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   890   C1704336:Skeletal muscle cell [Cell]
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C0596981:Muscle Cells [Cell]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the activity of their endogenous insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0243102:enzyme activity [Molecular Function]
   767   C1145751:insulin activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "inhibited by the same metalloendoprotease inhibitors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0445247:Same [Qualitative Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.235: J Cell Biochem 44:137151[Medline] Kayalar C, Wong W 1989 Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. 

Phrase: "J Cell Biochem 44"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "137151"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kayalar C,"

Phrase: "Wong W 1989 Metalloendoprotease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the differentiation of L6 myoblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1159966:myoblast differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation by the endogenous insulin-degrading enzyme."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3547574:insulin degradation [Molecular Function]
   767   C0678637:enzyme degradation [Laboratory Procedure]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
Processing 00000000.tx.236: J Biol Chem 264:89288934[Abstract/Free FullText] Kuo WL, Montag AG, Rosner MR 1993 Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. 

Phrase: "J Biol Chem 264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "89288934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo WL,"

Phrase: "Montag AG,"

Phrase: "Rosner MR 1993 Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "and"

Phrase: "developmentally"

Phrase: "regulated in various rat tissues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0040300:Tissues [Tissue]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   726 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.237: Endocrinology 132:604611[Abstract] Rivett A 1989 The multicatalytic proteinase of mammalian cells. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "604611"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rivett"

Phrase: "A 1989"

Phrase: "The multicatalytic proteinase of mammalian cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2258865:multicatalytic proteinase [Molecular Function]
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.238: Arch Biochem Biophys 268:18[Medline] Hofmann CA, Lotan RM, Ku WW, Oeltmann TN 1983 Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin. 

Phrase: "Arch Biochem Biophys 268"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "18"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hofmann CA,"

Phrase: "Lotan RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ku WW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1861696:WW [Disease or Syndrome]

Phrase: "Oeltmann TN 1983 Insulin-ricin B hybrid molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0567416:molecules [Substance]
   710 E C1521991:Molecular [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "an insulin-associated effect on cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.239: J Biol Chem 258:1177411779[Abstract/Free FullText] Miller DS 1988 Stimulation of RNA and protein synthesis by intracellular insulin. 

Phrase: "J Biol Chem 258"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1177411779"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller DS 1988 Stimulation of RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "protein synthesis by intracellular insulin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0597295:Protein Synthesis [Molecular Function]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.240: Science 240:506509[Medline] Draznin B, Trowbridge M 1982 Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hormone. 

Phrase: "Science 240"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "506509"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Draznin B,"

Phrase: "Trowbridge M 1982 Inhibition of intracellular proteolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2249698:inhibition of proteolysis [Organism Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0227525:Hepatocytes [Cell]
   793 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "possible role of internalized hormone."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.241: J Biol Chem 257:1198811993[Abstract/Free FullText] Peavy DE, Edmondson JW, Duckworth WC 1984 Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. 

Phrase: "J Biol Chem 257"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1198811993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Edmondson JW,"

Phrase: "Duckworth WC 1984 Selective effects of inhibitors of hormone processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.242: Endocrinology 114:753760[Abstract]

Phrase: "Endocrinology 114"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "753760"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

